Name
Health Outcomes Associated with Autoimmune Disease Control
Speakers
Executive Advisory Board (EAB) or Platinum Sponsor
EAB - abbvie
Content Presented on Behalf of
Executive Advisory Board (EAB)
Services/Agencies represented
Executive Advisory Board (EAB)
Session Type
Breakout
Date
Wednesday, March 5, 2025
Start Time
3:15 PM
End Time
4:15 PM
Room#/Location
Annapolis 3-4
Focus Areas/Topics
Clinical Care
Learning Outcomes
1. Describe the impact and burden of Autoimmune Disease in US
2. Outline the current treatment landscape and guideline recommendations for the treatment of Inflammatory Bowel Disease
3. Describe the unmet need in the treatment of Autoimmune Diseases
4. Review clinical data for Risankizumab and Upadacitinib
5. Discuss future goals in the treatment of Autoimmune Diseases
2. Outline the current treatment landscape and guideline recommendations for the treatment of Inflammatory Bowel Disease
3. Describe the unmet need in the treatment of Autoimmune Diseases
4. Review clinical data for Risankizumab and Upadacitinib
5. Discuss future goals in the treatment of Autoimmune Diseases
CE/CME Session
Non-CE Session
Session Currently Live